i:X. MolecuLight – BIBA Medtech Insights

MolecuLight to participate in virtual WoundCon 2020

MolecuLight is to sponsor and participate in the virtual exhibit of WoundCon Spring 2020—a one-day conference and exhibition to be held on 2 April 2020. According to a press release, WoundCon has become the largest conference for wound care, with more than 10,000 wound care professionals registered for the one-day clinical conference and virtual exhibition. [...]

FDA 510(k) clearance for its i:X handheld fluorescence imaging device for wound management

i:X MolecuLight has received FDA 510(k) clearance for its i:X handheld fluorescence imaging device for use in the detection of wounds containing bacteria. This FDA 510(k) clearance is an expansion of the original de novo clearance for the MolecuLight i:X platform, which was granted 14 August 2018. A press release reports that [...]